PTH – Invesco DWA Healthcare Momentum ETF
Invesco DWA Healthcare Momentum ETF (PTH) is a Health ETF, issued by Invesco, $261M in assets, 0.60% expense ratio.
Returns as of Oct 23, 2026: 1 week +4.7%, 1 year +58.5%.
Invests in at least 30 healthcare sector securities with strong relative strength or momentum characteristics.
Top holdings
- RVMD – Revolution Medicines Inc, 5.2%
- ROIV – Roivant Sciences Ltd, 5.1%
- GH – Guardant Health Inc, 4.7%
- BTSG – BrightSpring Health Services, Inc. Common Stock, 3.9%
- AXSM – Axsome Therapeutics Inc, 3.9%
- ORKA – Oruka Therapeutics, Inc., 3.0%
- ERAS – Erasca Inc, 2.8%
- TXG – 10X Genomics Inc, 2.7%
- REPL – Replimune Group Inc, 2.5%
- LQDA – Liquidia Technologies Inc, 2.5%
- RLAY – Relay Therapeutics Inc, 2.3%
- TVTX – Travere Therapeutics Inc, 2.3%
- AXGN – Axogen Inc, 2.3%
- MRNA – Moderna Inc, 2.1%
- TWST – Twist Bioscience Corp, 2.1%
- SYRE – Spyre Therapeutics Inc., 2.0%
- OSCR – Oscar Health Inc, 2.0%
- ARWR – Arrowhead Pharmaceuticals Inc, 2.0%
- BCTG – BCTG Acquisition Corp, 2.0%
- AGL – agilon health Inc, 1.9%
- ILMN – Illumina Inc, 1.9%
- CNC – Centene Corp, 1.8%
- JAZZ – Jazz Pharmaceuticals PLC, 1.8%
- HUM – Humana Inc, 1.8%
- ELVN – Enliven Therapeutics Inc., 1.7%